HR 4244
116th Congress
House
Health
Competition and antitrust
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Licensing and registrations
Manufacturing
Prescription drugs
MAGIC Act
Introduced: September 9, 2019
Introduced by:
Kelly, Mike
Republican
· Pennsylvania
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 10, 2019
Referred to the Subcommittee on Health.
Sep 9, 2019
Referred to the House Committee on Energy and Commerce.
Sep 9, 2019
Introduced in House
Plain-English summary
Market Access for Generic Insulin Competition or the MAGIC Act
This bill provides a pathway for the Food and Drug Administration to approve chemically synthesized insulin or an analogue of chemically synthesized insulin as a generic drug under the abbreviated new drug application process.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2